Forbes April 3, 2020
William A. Haseltine

How will the new coronavirus pandemic end?

It could prove to be seasonal, meaning it peters out with the weather with a chance of returning at this time next year. A significant plurality of all people on Earth could contract the disease—prolonging its duration, slowing it over time through a gradual buildup of herd immunity, and inevitability leading to the death of millions. Or one of the many pharmaceutical companies hard at work on inventing a vaccine could succeed and administer their product widely and cheaply, though at least a year will go by before this comes to pass.

Our best option—the option that will save the most lives in the least amount of time—is to accelerate the development of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma, Technology, Trends
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
STAT+: After AI protein folding, David Baker’s lab identifies millions of smaller drug candidates
Fierce Biotech Layoff Tracker 2024: BMS to cut 2K+ roles; Tessera trims workforce in shift to clinic
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise?

Share This Article